Market Place
Sourcing Support
Star Therapeutics Presents at 44th JP Morgan Healthcare Conf
05 Jan 2026 //
BUSINESSWIRE
Star Therapeutics` VGA039 Cuts VWD Bleeding at ASH
06 Dec 2025 //
BUSINESSWIRE
Star Tx To Present Interim Ph 1/2 VGA039 Data at ASH
03 Nov 2025 //
BUSINESSWIRE
Star Therapeutics Secures $125m In Series D Funding
30 Sep 2025 //
BUSINESSWIRE
Star Therapeutics Gains FDA Fast Track For VGA039 In VWD
06 Jan 2025 //
BUSINESSWIRE
Star Therapeutics to Present at 43rd Annual J.P. Morgan Conference
02 Jan 2025 //
BUSINESSWIRE
Star Therapeutics Presents Data for VGA039 in Von Willebrand at ASH
09 Dec 2024 //
BUSINESSWIRE
Star Therapeutics Presents Data For VGA039 Therapy for Von Willebrand Disease
26 Jun 2024 //
BUSINESSWIRE
Star Therapeutics Appoints Scott Robertson, MBA, as Chief Business Officer
03 Jan 2024 //
BUSINESSWIRE
Star Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference
02 Jan 2024 //
BUSINESSWIRE
Star Appoints Matthew Fust as Independent Director and Board Audit Chair
05 Dec 2023 //
BUSINESSWIRE
Star Therapeutics Raises $90 Million Financing
05 Sep 2023 //
BUSINESSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.